Del(17p) invariably comprises the tumor suppressor gene TP53, which is mutated in ∼10% of CLL cases at diagnosis and plays a critical role in the DDR pathway, apoptosis and cell cycle.24 The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.